China Universal Asset Management Co., Ltd. Taysha Gene Therapies, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 35,908 shares of TSHA stock, worth $74,329. This represents 0.01% of its overall portfolio holdings.
Number of Shares
35,908
Previous 35,908
-0.0%
Holding current value
$74,329
Previous $103,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding TSHA
# of Institutions
111Shares Held
109MCall Options Held
108KPut Options Held
158K-
Avoro Capital Advisors LLC New York, NY18.7MShares$38.6 Million0.65% of portfolio
-
Rtw Investments, LP New York, NY18.6MShares$38.5 Million0.86% of portfolio
-
Vr Adviser, LLC New York, NY9MShares$18.6 Million2.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.92MShares$12.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY5.17MShares$10.7 Million0.0% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $100M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...